Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer

BACKGROUND: Ovarian cancer (OC) is a leading cause of cancer-related death in women, and thus an accurate diagnosis of the predisposition and its early detection is necessary. The aims of this study were to determine whether serum exosomal microRNA-34a (miR-34a) in ovarian cancer could be used as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Kazuya, Sasaki, Hiroshi, Ueda, Shoko, Miyamoto, Shunsuke, Terada, Shinichi, Konishi, Hiromi, Kogata, Yuhei, Ashihara, Keisuke, Fujiwara, Satoe, Tanaka, Yoshimichi, Tanaka, Tomohito, Hayashi, Masami, Ito, Yuko, Kondo, Yoichi, Ochiya, Takahiro, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184688/
https://www.ncbi.nlm.nih.gov/pubmed/32336272
http://dx.doi.org/10.1186/s13048-020-00648-1
Descripción
Sumario:BACKGROUND: Ovarian cancer (OC) is a leading cause of cancer-related death in women, and thus an accurate diagnosis of the predisposition and its early detection is necessary. The aims of this study were to determine whether serum exosomal microRNA-34a (miR-34a) in ovarian cancer could be used as a potential biomarker. METHODS: Exosomes from OC patients’ serum were collected, and exosomal miRNAs were extracted. The relative expression of miR-34a was calculated from 58 OC samples by quantitative real-time polymerase chain reaction. RESULTS: Serum exosomal miR-34a levels were significantly increased in early-stage OC patients compared with advanced-stage patients. Its levels were significantly lower in patients with lymph node metastasis than in those with no lymph node metastasis. Furthermore, its levels in the recurrence group were significantly lower than those in the recurrence-free group. CONCLUSIONS: Serum exosomal miR-34a could be a potential biomarker for improving the diagnostic efficiency of OC.

Ejemplares similares